Evidence map›Paper›PMID 33742685›Full record

ReviewJournal of neurochemistry2021

Addiction-related neuroadaptations following chronic nicotine exposure.

Lauren Wills, Paul J Kenny

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Journal of neurochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07779161 (Effect of Reminder Strategies on No-Show Rates in a Nicotine Cessation Clinic), which is not on this map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07779161 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Effect of Reminder Strategies on No-Show Rates in a Nicotine Cessation Clinic: A Randomized Controlled Trial

TypeinterventionalSponsorMedical University of GdanskRan2026 to 2027Enrolled300ConditionsBehavioral Intervention, Nicotine AddictionArmsStandard phone call, phone call with MINDSPACE elements
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Nicotine addiction: More than just dopamine.Current opinion in neurobiology · 2023
    Review
  19. Article
  20. Association of the rs3864283 Polymorphism Located in theInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lauren WillsNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, USA.
Paul J KennyNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, USA.ORCID 0000-0003-2426-3641
Icahn School of Medicine at Mount Sinai · US

Funding

Role for Tas2Rs in opioid addictionR37DA020686 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Paul J. Kenny · 2018 to 2026
$3.7M
Mechanisms of nicotine reinforcement in miceR01DA020686 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI KENNY, PAUL J. · 2007 to 2016
$3.6M
Habenular immune signaling and addictionR01DA045649 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KENNY, PAUL J. · 2018 to 2022
$3.1M
NIDA NIH HHS DA020686NIDA NIH HHS DA045649NIDA NIH HHS R01 DA045649NIDA NIH HHS R37 DA020686
6 · The paper itself

Abstract

The addiction-relevant molecular, cellular, and behavioral actions of nicotine are derived from its stimulatory effects on neuronal nicotinic acetylcholine receptors (nAChRs) in the central nervous system. nAChRs expressed by dopamine-containing neurons in the ventral midbrain, most notably in the ventral tegmental area (VTA), contribute to the reward-enhancing properties of nicotine that motivate the use of tobacco products. nAChRs are also expressed by neurons in brain circuits that regulate aversion. In particular, nAChRs expressed by neurons in the medial habenula (mHb) and the interpeduncular nucleus (IPn) to which the mHb almost exclusively projects regulate the "set-point" for nicotine aversion and control nicotine intake. Different nAChR subtypes are expressed in brain reward and aversion circuits and nicotine intake is titrated to maximally engage reward-enhancing nAChRs while minimizing the recruitment of aversion-promoting nAChRs. With repeated exposure to nicotine, reward- and aversion-related nAChRs and the brain circuits in which they are expressed undergo adaptations that influence whether tobacco use will transition from occasional to habitual. Genetic variation that influences the sensitivity of addiction-relevant brain circuits to the actions of nicotine also influence the propensity to develop habitual tobacco use. Here, we review some of the key advances in our understanding of the mechanisms by which nicotine acts on brain reward and aversion circuits and the adaptations that occur in these circuits that may drive addiction to nicotine-containing tobacco products.

Indexed as

Adaptation, PhysiologicalAnimalsDopamineHumansNicotineReceptors, NicotinicRewardTobacco Use DisorderDopamineNicotineReceptors, Nicotinicaddictiondesensitizationdopaminehabenulainterpeduncular nucleusNicotinenicotinic acetylcholine receptorrewardwithdrawal

Identifiers

PMID33742685
PMCPMC13249106
OpenAlexW3137382578

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.